Raman spectroscopy for detection of imatinib in plasma: A proof of concept

Imatinib is the standard first line treatment for chronic myeloid leukemia (CML). Owing to doserelated toxicities of Imatinib such as neutropenia, there is scope for treatment optimization through therapeutic drug monitoring (TDM). Trough concentration of 1 μg/mL is considered the therapeutic thresh